Antimicrobial resistance is a major public health problem globally. Likewise, forms of
tuberculosis (TB) resistant to first- and second-line TB medicines present a major challenge for …

Christian Lienhardt and co-authors discuss the conclusions of the PLOS Medicine Collection
on advances in clinical trial design for development of new tuberculosis treatments.

Discussion Globally, although TB incidence and mortality have been steadily decreasing,
these declines are likely not occurring quickly enough for WHO End TB Strategy targets to be …

… Kerri Viney, Nguyen Nhat Linh, Medea Gegia, Matteo Zignol, Philippe Glaziou, Nazir
Ismail,Tereza Kasaeva, Fuad Mirzayev … In addition, we thank the WHO staff who attended …

Covid-19’s Devastating Effect on Tuberculosis Care — A Path to Recovery | NEJM Skip to main
content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to …

收录了- - - - - -Brasil - Mapping the tuberculosis scientific landscape among BRICS countries: a
bibliometric and network analysis Mapping the tuberculosis scientific landscape among …

Objective Having up-to-date health policy recommendations accessible in one location is in
high demand by guideline users. We developed an easy to navigate interactive approach to …

The scale-up of tuberculosis (TB) preventive treatment (TPT) must be accelerated to achieve
the targets set by the United Nations High-level Meeting on TB and the End TB Strategy. …

Tuberculosis is second only to COVID-19 as a cause of death from a single infectious agent.
In 2020, almost 10 million people were estimated to have developed tuberculosis and it …

In recent years, tremendous global efforts have been made to tackle tuberculosis (TB). Until
recently, however, the range of interventions had been mainly limited to the health domain, …